New Zealand markets close in 1 hour 13 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
144.27+1.01 (+0.71%)
At close: 04:00PM EDT
143.76 -0.51 (-0.36%)
After hours: 07:59PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
22,600,000
18,471,000
803,395
60,209
135,068
Cost of revenue
3,441,000
2,617,000
7,933
-
-
Gross profit
19,159,000
15,854,000
795,462
-
-
Operating expenses
Research development
2,144,000
1,991,000
1,370,339
496,309
454,082
Selling general and administrative
758,000
567,000
188,267
109,620
94,252
Total operating expenses
2,902,000
2,558,000
1,558,606
605,929
548,334
Operating income or loss
16,257,000
13,296,000
-763,144
-545,720
-413,266
Interest expense
21,000
18,000
9,886
6,612
-
Total other income/expenses net
-11,000
-11,000
3,802
-914
1,835
Income before tax
16,254,000
13,285,000
-744,513
-514,716
-384,408
Income tax expense
1,616,000
1,083,000
2,551
-695
326
Income from continuing operations
14,638,000
12,202,000
-747,064
-514,021
-384,734
Net income
14,638,000
12,202,000
-747,064
-514,021
-384,734
Net income available to common shareholders
14,638,000
12,202,000
-747,064
-514,021
-401,857
Basic EPS
-
30.31
-1.96
-1.55
-1.17
Diluted EPS
-
28.29
-1.96
-1.55
-1.17
Basic average shares
-
403,000
381,333
330,802
328,799
Diluted average shares
-
431,000
381,333
330,802
328,799
EBITDA
-
13,535,000
-703,376
-477,083
-388,404